World's Best Scientists 2026 revealed!
Zicai Liang

Zicai Liang

D-Index & Metrics

Molecular Biology

D-Index
58
Citations
12900
World Ranking
2080
National Ranking
58

Zicai Liang publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Zicai Liang sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 149 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Zicai Liang D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Zicai Liang sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Zicai Liang is affiliated with Peking University in China, focusing primarily on research intersecting medicine and biochemistry, genetics, and molecular biology. Their work encompasses 22 publications in medicine and 14 in biochemistry and related fields.

Their research spans several subfields, including molecular biology, epidemiology, hematology, endocrinology, diabetes and metabolism, and immunology. The subfields with the highest publication counts are molecular biology with 12 and epidemiology, hematology, and endocrinology with 5 each.

Main topics of Zicai Liang's work include:

  • RNA Interference and Gene Delivery
  • Hepatitis B Virus Studies
  • Blood Coagulation and Thrombosis Mechanisms
  • Diabetes Management and Research
  • Advanced biosensing and bioanalysis techniques
  • Dendrimers and Hyperbranched Polymers
  • Advancements in Transdermal Drug Delivery

Frequent publication venues where Liang's research has appeared include:

  • Journal of Hepatology (3 papers)
  • Journal of Thrombosis and Haemostasis (2 papers)
  • Diabetes Therapy (2 papers)
  • Nano Letters
  • Bioactive Materials

Among notable recent papers are:

  • "Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA," 2021, Nano Letters
  • "Efficient hepatic delivery and protein expression enabled by optimized mRNA and ionizable lipid nanoparticle," 2020, Bioactive Materials
  • "Rolling microneedle electrode array (RoMEA) empowered nucleic acid delivery and cancer immunotherapy," 2020, Nano Today
  • "The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer," 2020, Journal of Thrombosis and Haemostasis
  • "Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B," 2022, Signal Transduction and Targeted Therapy

Frequent collaborators in Liang's research include Yuanyu Huang, Xing-Jie Liang, Chunhui Li, Tongren Yang, and Jun Zhang.

Best Publications

  • Antisense Transcription in the Mammalian Transcriptome

    S. Katayama;Y. Tomaru;T. Kasukawa;K. Waki

  • Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality

    Joacim Elmén;Håkan Thonberg;Karl Ljungberg;Miriam Frieden

  • Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation

    Defang Li;Jin Liu;Baosheng Guo;Chao Liang

  • Enhanced Gene Delivery and siRNA Silencing by Gold Nanoparticles Coated with Charge-Reversal Polyelectrolyte

    Shutao Guo;Yuanyu Huang;Qiao Jiang;Yun Sun

  • Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance

    Tuo Wei;Chao Chen;Juan Liu;Cheng Liu

  • Hypoxia-independent angiogenesis in adipose tissues during cold acclimation.

    Yuan Xue;Natasa Petrovic;Renhai Cao;Ola Larsson

  • Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

    Chao Liang;Baosheng Guo;Heng Wu;Ningsheng Shao

  • A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites

    Quan Du;Håkan Thonberg;Jue Wang;Claes Wahlestedt

  • Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway.

    Xiao Zhou;Xiaorui Han;Ann Wittfeldt;Jingzhi Sun

  • Adaptive amphiphilic dendrimer-based nanoassemblies as robust and versatile siRNA delivery systems.

    Xiaoxuan Liu;Jiehua Zhou;Tianzhu Yu;Chao Chen

  • Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.

    Juan Liu;Tuo Wei;Jing Zhao;Yuanyu Huang

  • An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples

    Jianhua Xiong;Dianke Yu;Na Wei;Hanjiang Fu

  • Functionalized nanoscale micelles improve drug delivery for cancer therapy in vitro and in vivo.

    Tuo Wei;Juan Liu;Huili Ma;Qiang Cheng

  • Structure and biological activity of a 1,3-beta-D-glucan-binding protein in crustacean blood.

    L. Cerenius;Zicai Liang;B. Duvic;P. Keyser

  • Systemic Administration of Combinatorial dsiRNAs via Nanoparticles Efficiently Suppresses HIV-1 Infection in Humanized Mice

    Jiehua Zhou;C Preston Neff;Xiaoxuan Liu;Xiaoxuan Liu;Jane Zhang

  • Pacifastin, a novel 155-kDa heterodimeric proteinase inhibitor containing a unique transferrin chain

    Zicai Liang;Lars Sottrup-Jensen;Anna Aspán;Martin Hall

  • Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.

    J Xiong;Q Du;Z Liang

  • Elimination Pathways of Systemically Delivered siRNA

    Yuanyu Huang;Junmei Hong;Shuquan Zheng;Yi Ding

  • MALAT-1 interacts with hnRNP C in cell cycle regulation

    Feng Yang;Fan Yi;Xiaorui Han;Quan Du

  • Silanized nucleic acids: a general platform for DNA immobilization.

    Anil Kumar;Ola Larsson;Daniela Parodi;Zicai Liang

Frequent Co-Authors

Claes Wahlestedt
Claes Wahlestedt University of Miami
Anjie Dong
Anjie Dong Tianjin University
Xing-Jie Liang
Xing-Jie Liang National Center for Nanoscience and Technology, China
Liandong Deng
Liandong Deng Tianjin University
Zhen Xi
Zhen Xi Nankai University
Ola Larsson
Ola Larsson Science for Life Laboratory
Ling Peng
Ling Peng Aix-Marseille University
Ge Zhang
Ge Zhang Hong Kong Baptist University
Aiping Lu
Aiping Lu Hong Kong Baptist University
Kenneth Söderhäll
Kenneth Söderhäll Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a future beyond Molecular Biology, several online degree and career pathways offer flexibility and new opportunities. If you’re interested in speech-language pathology, programs like an slp bridge program online are available for those with non-SLP backgrounds, enabling a career shift with streamlined coursework.

Additionally, healthcare attracts many molecular biology graduates due to overlapping skills. Fast-tracked, flexible options such as the best online bsn programs for non nurses allow students to earn a nursing degree even without prior nursing experience.

Advancing in the field, the role of a psychiatric nurse practitioner is growing, with compensation varying by region. For an overview of potential earnings, review the dnp psychiatric nurse practitioner salary by state.

If you’re curious how quickly you could transition into an advanced nursing career, learn more about how many years to become a nurse practitioner and plan your next educational move with confidence.

Best Scientists Citing Zicai Liang

Trending Scientists

Recently Published Articles